                         SEQUENCE LISTING

<110>  Cel-Sci
 
<120>  NOVEL PEPTIDES FOR VACCINATION AND TREATMENT OF 2019-nCoV 
       INFECTIONS

<130>  CS-143/PCT

<160>  24    

<170>  PatentIn version 3.5

<210>  1
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  From 2019-nCoV

<400>  1

Gly Thr Arg Asn Pro Ala Asn Asn Ala Ala 
1               5                   10  


<210>  2
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  From SARS-CoV Virus

<400>  2

Gly Thr Arg Asn Pro Asn Asn Asn Ala Ala 
1               5                   10  


<210>  3
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  From 2019-nCoV Virus

<400>  3

Val Ile Leu Leu Asn Lys His Ile Asp Ala Tyr Lys Thr Phe 
1               5                   10                  


<210>  4
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  From MERS-coV Virus

<400>  4

Gly Thr Arg Asn Pro Asn Asn Asp Ser Ala 
1               5                   10  


<210>  5
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  From MERS-CoV Virus

<400>  5

Leu Glu Leu Leu Glu Gln Asn Ile Asp Ala Tyr Lys Thr Phe 
1               5                   10                  


<210>  6
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  From 2019-nCoV virus

<400>  6

Ile Gly Thr Arg Asn Pro Ala Asn Asn Ala Ala Ile Val Leu Pro 
1               5                   10                  15  


<210>  7
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized peptide construct

<400>  7

Asp Gly Gln Glu Glu Lys Ala Gly Val Val Ser Thr Gly Leu Ile 
1               5                   10                  15  


<210>  8
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized peptide construct

<400>  8

Asp Leu Leu Lys Asn Gly Glu Arg Ile Glu Lys Val Glu 
1               5                   10              


<210>  9
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized peptide construct

<400>  9

Asp Leu Leu Lys Asn Gly Glu Arg Ile Glu Lys Val Glu Gly Gly Gly 
1               5                   10                  15      


Val Ile Leu Leu Asn Lys His Ile Asp Ala Tyr Lys Thr Phe 
            20                  25                  30  


<210>  10
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized peptide construct

<400>  10

Asp Leu Leu Lys Asn Gly Glu Arg Ile Glu Lys Val Glu Gly Gly Gly 
1               5                   10                  15      


Ile Gly Thr Arg Asn Pro Ala Asn Asn Ala Ala Ile Val Leu Pro 
            20                  25                  30      


<210>  11
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized peptide construct

<400>  11

Asp Gly Gln Glu Glu Lys Ala Gly Val Val Ser Thr Gly Leu Ile Gly 
1               5                   10                  15      


Gly Gly Val Ile Leu Leu Asn Lys His Ile Asp Ala Tyr Lys Thr Phe 
            20                  25                  30          


<210>  12
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized peptide construct

<400>  12

Asp Gly Gln Glu Glu Lys Ala Gly Val Val Ser Thr Gly Leu Ile Gly 
1               5                   10                  15      


Gly Gly Ile Gly Thr Arg Asn Pro Ala Asn Asn Ala Ala Ile Val Leu 
            20                  25                  30          


Pro 
    


<210>  13
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  From 2019-nCoV virus

<400>  13

Pro Gln Asn Gln Arg Asn Ala Pro Arg Ile Thr Phe Gly Gly Pro Ser 
1               5                   10                  15      


Asp Ser Thr Gly Ser Asn Gln 
            20              


<210>  14
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  From 2019-nCoV virus

<400>  14

Tyr Lys His Trp Pro Gln Ile Ala Gln Phe Ala Pro Ser Ala Ser Ala 
1               5                   10                  15      


Phe Phe Gly Met Ser Arg 
            20          


<210>  15
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  From 2019-nCoV virus

<400>  15

Gly Ala Leu Asn Thr Pro Lys Asp His Ile Gly Thr Arg Asn Pro Ala 
1               5                   10                  15      


Asn Asn Ala Ala Ile Val Leu 
            20              


<210>  16
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized Peptide Construct

<400>  16

Asp Leu Leu Lys Asn Gly Glu Arg Ile Glu Lys Val Glu Gly Gly Gly 
1               5                   10                  15      


Pro Gln Asn Gln Arg Asn Ala Pro Arg Ile Thr Phe Gly Gly Pro Ser 
            20                  25                  30          


Asp Ser Thr Gly Ser Asn Gln 
        35                  


<210>  17
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized peptide construct

<400>  17

Asp Leu Leu Lys Asn Gly Glu Arg Ile Glu Lys Val Glu Gly Gly Gly 
1               5                   10                  15      


Tyr Lys His Trp Pro Gln Ile Ala Gln Phe Ala Pro Ser Ala Ser Ala 
            20                  25                  30          


Phe Phe Gly Met Ser Arg 
        35              


<210>  18
<211>  39
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Syntesized peptide construct

<400>  18

Asp Leu Leu Lys Asn Gly Glu Arg Ile Glu Lys Val Glu Gly Gly Gly 
1               5                   10                  15      


Gly Ala Leu Asn Thr Pro Lys Asp His Ile Gly Thr Arg Asn Pro Ala 
            20                  25                  30          


Asn Asn Ala Ala Ile Val Leu 
        35                  


<210>  19
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized peptide construct

<400>  19

Asp Gly Gln Glu Glu Lys Ala Gly Val Val Ser Thr Gly Leu Ile Gly 
1               5                   10                  15      


Gly Gly Pro Gln Asn Gln Arg Asn Ala Pro Arg Ile Thr Phe Gly Gly 
            20                  25                  30          


Pro Ser Asp Ser Thr Gly Ser Asn Gln 
        35                  40      


<210>  20
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized peptide construct

<400>  20

Asp Gly Gln Glu Glu Lys Ala Gly Val Val Ser Thr Gly Leu Ile Gly 
1               5                   10                  15      


Gly Gly Tyr Lys His Trp Pro Gln Ile Ala Gln Phe Ala Pro Ser Ala 
            20                  25                  30          


Ser Ala Phe Phe Gly Met Ser Arg 
        35                  40  


<210>  21
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized peptide construct

<400>  21

Asp Gly Gln Glu Glu Lys Ala Gly Val Val Ser Thr Gly Leu Ile Gly 
1               5                   10                  15      


Gly Gly Gly Ala Leu Asn Thr Pro Lys Asp His Ile Gly Thr Arg Asn 
            20                  25                  30          


Pro Ala Asn Asn Ala Ala Ile Val Leu 
        35                  40      


<210>  22
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  From SARS-CoV Virus

<400>  22

Gly Asn Tyr Asn Tyr Leu Tyr Arg Leu Phe Arg Lys Ser Asn Leu Lys 
1               5                   10                  15      


<210>  23
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized peptide construct

<400>  23

Asp Leu Leu Lys Asn Gly Glu Arg Ile Glu Lys Val Glu Gly Gly Gly 
1               5                   10                  15      


Gly Asn Tyr Asn Tyr Leu Tyr Arg Leu Phe Arg Lys Ser Asn Leu Lys 
            20                  25                  30          


<210>  24
<211>  34
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesized peptide construct

<400>  24

Asp Gly Gln Glu Glu Lys Ala Gly Val Val Ser Thr Gly Leu Ile Gly 
1               5                   10                  15      


Gly Gly Gly Asn Tyr Asn Tyr Leu Tyr Arg Leu Phe Arg Lys Ser Asn 
            20                  25                  30          


Leu Lys 
        


